DaVita Inc. (NYSE:DVA) Receives $166.33 Average Target Price from Brokerages

Shares of DaVita Inc. (NYSE:DVA) have earned an average rating of “Hold” from the six analysts that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $166.33.

A number of research analysts have recently commented on the stock. Cowen restated a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. StockNews.com upgraded DaVita from a “hold” rating to a “buy” rating in a research report on Friday, April 25th. Sanford C. Bernstein set a $184.00 price target on DaVita in a report on Friday, February 21st. Finally, Barclays boosted their price objective on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th.

DaVita Trading Up 0.9 %

NYSE:DVA opened at $142.79 on Friday. DaVita has a 1 year low of $131.44 and a 1 year high of $179.60. The stock’s fifty day moving average price is $145.88 and its two-hundred day moving average price is $154.27. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The company has a market cap of $10.98 billion, a P/E ratio of 13.30, a P/E/G ratio of 1.07 and a beta of 1.14.

DaVita (NYSE:DVA) last released its quarterly earnings data on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. As a group, analysts expect that DaVita will post 10.76 EPS for the current year.

Institutional Investors Weigh In On DaVita

Hedge funds have recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its position in DaVita by 65.5% in the 1st quarter. UMB Bank n.a. now owns 192 shares of the company’s stock worth $29,000 after buying an additional 76 shares during the last quarter. Copia Wealth Management bought a new stake in shares of DaVita in the 4th quarter worth approximately $30,000. SBI Securities Co. Ltd. purchased a new stake in shares of DaVita in the 4th quarter valued at $41,000. Coppell Advisory Solutions LLC grew its holdings in shares of DaVita by 50.0% during the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company’s stock valued at $45,000 after purchasing an additional 100 shares during the last quarter. Finally, Canada Post Corp Registered Pension Plan purchased a new position in DaVita in the 4th quarter worth $55,000. Institutional investors own 90.12% of the company’s stock.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.